Enzymes act like a switch, turning antibiotic resistance on and off in enterococci

Oct 31, 2011

Antibiotic-resistant enterococci are a serious problem for patients in the hospital, but little is known about how these bacteria are able to escape antibiotics. New discoveries about the ways in which enterococci turn their resistance to cephalosporin antibiotics on and off are described in a study that will be published November 1 in the online journal mBio. The new details about resistance could lead to new therapies for preventing and treating enterococcal infections.

Enterococcus faecalis isn't always a deadly pathogen. Normally a friendly resident of the , in individuals who are immune compromised E. faecalis can turn ugly. Infecting the , urinary tract, and surgical sites. Patients who are given cephalosporin antibiotics for other problems are also prone to opportunistic E. faecalis infection, since the bacterium is naturally resistant to these antibiotics and flourishes when sensitive are killed off. Cephalosporins are like a last resort for treating infections that are resistant to other, less powerful drugs, so a patient treated with cephalosporins who acquires an E. faecalis infection essentially goes from the frying pan (their original infection) and into the fire (E. faecalis ).

But how do enterococci overcome cephalosporin ? Despite the importance of this pathogen in hospitals, scientists still know relatively little about how enterococci skirt cephalosporin attacks. Chris Kristich and his colleagues at the Medical College of Wisconsin have uncovered new details about the bacterium's ability to turn resistance on and off, a development that could lead to new therapies for enterococcal infections.

According to Kristich, the enzyme IreK is involved in resistance to cephalosporins, since enterococci that lack it are much more sensitive to the drugs. IreK is a kinase – an enzyme that carries phosphate groups. The study coming out in mBio details new findings about another aspect of resistance control: an enzyme called IreP, which takes phosphates off of IreK, thus controlling how active IreK is in the bacterium.

"Phosphorylating IreK changes the activity of the kinase – it's a way to turn it on and off," says Kristich. "The result of that actually is to regulate the level of the output – it is reflected by the level of cephalosporin resistance."

Kristich says the bacterium probably needs a way to turn resistance on and off because maintaining the cellular machinery for resistance costs the cell important resources. "We don't know exactly how [enterococci become resistant to cephalosporins]. Whatever the mechanism, it may be costly when there's no cephalosporin around," says Kristich.

The problem with enterococcal infections is not going to get better until new therapies and preventive strategies can be developed, says Kristich. Knowing more about how the can go back and forth from sensitive to resistant and back can help lead researchers to ways of controlling infections. "There's an opportunity to develop a new strategy by understanding the basis for cephalosporin resistance," says Kristich. "If we could figure out a way to make enterococci susceptible to cephalosporins, they could be used to treat or prevent these infections."

Explore further: Scientists find key to te first cell differentiation in mammals

Provided by American Society for Microbiology

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Burden of antibiotic resistance in Europe

Oct 11, 2011

Hospital associated infections (HAI) are often in the headlines, but what is the burden of mortality, morbidity and costs due to HAIs? In this week's PLoS Medicine, Marlieke de Kraker, Peter Davey and Hajo Grundmann, on beh ...

Growing concern over drugs fed to animals

Sep 19, 2011

Drugs fed to animals to promote growth and prevent diseases may play a key role in the emergence of antibiotic resistant bacteria, microbiologists said Sunday.

Scientists re-engineer antibiotic

Feb 09, 2006

Scientists have re-engineered an antibiotic that attacks bacteria by inhibiting cell wall synthesis, thereby significantly increasing its effectiveness.

Recommended for you

Research helps identify memory molecules

17 hours ago

A newly discovered method of identifying the creation of proteins in the body could lead to new insights into how learning and memories are impaired in Alzheimer's disease.

Computer simulations visualize ion flux

18 hours ago

Ion channels are involved in many physiological and pathophysiological processes throughout the human body. A young team of researchers led by pharmacologist Anna Stary-Weinzinger from the Department of Pharmacology ...

Neutron diffraction sheds light on photosynthesis

18 hours ago

Scientists from ILL and CEA-Grenoble have improved our understanding of the way plants evolved to take advantage of sunlight. Using cold neutron diffraction, they analysed the structure of thylakoid lipids found in plant ...

DNA may have had humble beginnings as nutrient carrier

Sep 01, 2014

New research intriguingly suggests that DNA, the genetic information carrier for humans and other complex life, might have had a rather humbler origin. In some microbes, a study shows, DNA pulls double duty ...

Central biobank for drug research

Sep 01, 2014

For the development of new drugs it is crucial to work with stem cells, as these allow scientists to study the effects of new active pharmaceutical ingredients. But it has always been difficult to derive ...

User comments : 0